Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity

被引:31
作者
Mai, Kien T. [1 ]
Kohler, Derek M.
Belanger, Eric C.
Robertson, Susan J.
Wang, Don
机构
[1] Ottawa Gen Hosp, Div Anat Pathol, Dept Lab Med, Ottawa, ON K1H 8L6, Canada
关键词
clear cell; kidney; carcinoma; cytokeratin; 7;
D O I
10.1080/00313020802197962
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: Clear cell renal cell carcinoma (CRCC) with diffuse immunoreactivity for CK7 is described. Methods: All cases of CRCC, measuring 20mm or less in diameter over a period of 10 years, were examined. Areas of regenerative epithelial cell nests (REC) were also examined. Results: Fifteen specimens containing 29 nodules were diagnosed as CRCC due to the characteristic clear cytoplasm. Of these 29 nodules, 21 showed diffuse CK7 positivity while eight showed CK7 negativity. The CK7 positive CRCC measured less than 16mm and contained varying proportions of tumour cells with chromophil cytoplasm. Architecturally, CK7 positive CRCC consisted of cysts and solid cell nests with tubulo-acinar formations or papillary formations. Immunostaining for AMACR, CD10 and RCC showed negative or focal reactivity in the CK7 positive CRCC, frequently positive reactivity in CK7 negative CRCC and negative reactivity in REC which also displayed strong CK7 reactivity. The ten patients with 21 CK7 positive CRCC developed no metastatic disease over a follow up time that ranged from 1 to 10 years (mean of 3 years). Conclusions: CRCC characterised by diffuse CK7 positivity represents a distinct type of CRCC with characteristic histopathological and immunohistochemical features.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 18 条
[1]   Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms [J].
Avery, AK ;
Beckstead, J ;
Renshaw, AA ;
Corless, CL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (02) :203-210
[2]  
BERGSTRAND A, 1985, CLIN NEPHROL, V24, P107
[3]  
Delahunt B, 1997, MODERN PATHOL, V10, P537
[4]   Immunohistochemical profile of common epithelial neoplasms arising in the kidney [J].
Kim, MK ;
Kim, S .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (04) :332-338
[5]  
Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO
[6]  
2-G
[7]   MOLECULAR DIFFERENTIAL PATHOLOGY OF RENAL-CELL TUMORS [J].
KOVACS, G .
HISTOPATHOLOGY, 1993, 22 (01) :1-8
[8]   Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy [J].
Lau, WK ;
Cheville, JC ;
Blute, ML ;
Weaver, AL ;
Zincke, H .
UROLOGY, 2002, 59 (04) :532-537
[9]   Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study [J].
Mazal, PR ;
Stichenwirth, M ;
Koller, A ;
Blach, S ;
Haitel, A ;
Susani, M .
MODERN PATHOLOGY, 2005, 18 (04) :535-540
[10]   Diagnosing primary and metastatic renal cell carcinoma - The use of the monoclonal antibody 'renal cell carcinoma marker' [J].
McGregor, DK ;
Khurana, KK ;
Cao, C ;
Tsao, CC ;
Ayala, G ;
Krishnan, B ;
Ro, JY ;
Lechago, J ;
Truong, LD .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (12) :1485-1492